Homozygous mutations in PALB2 are linked to Fanconi’s anemia, while heterozygous mutations in PALB2 are related to developing of breast cancer risk in women with a clear family history of breast cancer [70, 143]. This evidence concerns the gene PALB2 and Fanconi anemia.